Aduro Biotech Receives Milestone Payment From Janssen for Acceptance…
Aduro Biotech, Inc. today announced that it has received a milestone payment from Janssen Biotech, Inc. for the acceptance of an Investigational New Drug Application by the U.S. Food and Drug Administration for ADU-741, a LADD immunotherapy product can…